BLFS
Price
$24.62
Change
+$3.28 (+15.37%)
Updated
May 9, 12:25 PM (EDT)
Capitalization
810.87M
90 days until earnings call
STXS
Price
$2.16
Change
+$0.07 (+3.35%)
Updated
May 8 closing price
Capitalization
214.36M
3 days until earnings call
Ad is loading...

BLFS vs STXS

Header iconBLFS vs STXS Comparison
Open Charts BLFS vs STXSBanner chart's image
BioLife Solutions
Price$24.62
Change+$3.28 (+15.37%)
Volume$700
Capitalization810.87M
Stereotaxis
Price$2.16
Change+$0.07 (+3.35%)
Volume$244.64K
Capitalization214.36M
BLFS vs STXS Comparison Chart
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. STXS commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and STXS is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BLFS: $21.34 vs. STXS: $2.16)
Brand notoriety: BLFS and STXS are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 0% vs. STXS: 49%
Market capitalization -- BLFS: $810.87M vs. STXS: $214.36M
BLFS [@Medical Specialties] is valued at $810.87M. STXS’s [@Medical Specialties] market capitalization is $214.36M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileSTXS’s FA Score has 0 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • STXS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BLFS and STXS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 3 TA indicator(s) are bullish while STXS’s TA Score has 6 bullish TA indicator(s).

  • BLFS’s TA Score: 3 bullish, 8 bearish.
  • STXS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, STXS is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -13.25% price change this week, while STXS (@Medical Specialties) price change was +6.93% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.58%. For the same industry, the average monthly price growth was +8.14%, and the average quarterly price growth was -3.58%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

STXS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Medical Specialties (+2.58% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than STXS($214M). STXS YTD gains are higher at: -5.263 vs. BLFS (-17.797). STXS has higher annual earnings (EBITDA): -21.24M vs. BLFS (-45.24M). BLFS has more cash in the bank: 51.7M vs. STXS (19.8M). STXS has less debt than BLFS: STXS (5.49M) vs BLFS (42.7M). BLFS has higher revenues than STXS: BLFS (143M) vs STXS (26.8M).
BLFSSTXSBLFS / STXS
Capitalization811M214M379%
EBITDA-45.24M-21.24M213%
Gain YTD-17.797-5.263338%
P/E Ratio238.10N/A-
Revenue143M26.8M534%
Total Cash51.7M19.8M261%
Total Debt42.7M5.49M778%
FUNDAMENTALS RATINGS
BLFS vs STXS: Fundamental Ratings
BLFS
STXS
OUTLOOK RATING
1..100
727
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
76100
SMR RATING
1..100
9197
PRICE GROWTH RATING
1..100
6045
P/E GROWTH RATING
1..100
1456
SEASONALITY SCORE
1..100
2250

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

STXS's Valuation (92) in the Medical Specialties industry is in the same range as BLFS (95). This means that STXS’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (76) in the Medical Specialties industry is in the same range as STXS (100). This means that BLFS’s stock grew similarly to STXS’s over the last 12 months.

BLFS's SMR Rating (91) in the Medical Specialties industry is in the same range as STXS (97). This means that BLFS’s stock grew similarly to STXS’s over the last 12 months.

STXS's Price Growth Rating (45) in the Medical Specialties industry is in the same range as BLFS (60). This means that STXS’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is somewhat better than the same rating for STXS (56). This means that BLFS’s stock grew somewhat faster than STXS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSSTXS
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 8 days ago
79%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Ad is loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGOYX68.59N/A
N/A
Hartford Growth Opportunities Y
MAEGX13.80N/A
N/A
BlackRock Unconstrained Equity Instl
RICIX10.61N/A
N/A
T. Rowe Price Intl Disciplined Eq I
CBEAX10.09N/A
N/A
Allspring Large Cap Value CL A
MGPIX98.90N/A
N/A
ProFunds Mid Cap Growth Inv

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
N/A
RGEN - BLFS
57%
Loosely correlated
+0.76%
DHR - BLFS
49%
Loosely correlated
+0.90%
RVTY - BLFS
47%
Loosely correlated
+1.43%
A - BLFS
47%
Loosely correlated
+1.10%
GH - BLFS
46%
Loosely correlated
+4.88%
More

STXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, STXS has been loosely correlated with SMTI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if STXS jumps, then SMTI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STXS
1D Price
Change %
STXS100%
+3.35%
SMTI - STXS
41%
Loosely correlated
+1.76%
RGEN - STXS
35%
Loosely correlated
+0.76%
BLFS - STXS
33%
Loosely correlated
N/A
SHC - STXS
33%
Loosely correlated
+0.61%
TWST - STXS
33%
Loosely correlated
-0.52%
More